These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 217315)

  • 1. On betaH-Leu5-endorphin and schizophrenia.
    Lewis RV; Gerber LD; Stein S; Stephen RL; Grosser BI; Velick SF; Udenfriend S
    Arch Gen Psychiatry; 1979 Feb; 36(2):237-9. PubMed ID: 217315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endorphins in schizophrenia: hemodialysis/hemoperfusion are ineffective in clearing beta-Leu5-endorphin and beta-endorphin from human plasma.
    Höllt V; Hillebrand G; Schmidt B; Gurland HJ
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):399-406. PubMed ID: 538084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma beta-endorphin immunoreactivity in schizophrenia.
    Ross M; Berger PA; Goldstein A
    Science; 1979 Sep; 205(4411):1163-4. PubMed ID: 472735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and immunological characterization of the Leu5 analogue of human beta-endorphin.
    Cox BM; Ross M; Goldstein A; Palmour RM
    Brain Res; 1979 Apr; 165(2):311-9. PubMed ID: 217494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients.
    Pickar D; Davis GC; Schulz SC; Extein I; Wagner R; Naber D; Gold PW; van Kammen DP; Goodwin FK; Wyatt RJ; Li CH; Bunney WE
    Am J Psychiatry; 1981 Feb; 138(2):160-6. PubMed ID: 6257125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some recent biochemical findings with possible therapeutic implications for schizophrenia.
    Ban TA
    J Clin Psychiatry; 1978 Jun; 39(6):535-6, 541. PubMed ID: 207679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma beta-endorphin levels in chronic schizophrenic patients normal controls.
    Espinosa-Meléndez E; Lal S; Nair NP; Chang TM
    Artif Organs; 1979 Nov; 3(4):375-7. PubMed ID: 533431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-Endorphin. Synthesis and properties of double-headed and related analogs.
    Yamashiro D; Li CH; Nicolas P; Hammonds RG
    Int J Pept Protein Res; 1982 Apr; 19(4):348-53. PubMed ID: 6288593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Endorphin: synthesis and analgesic activity of several analogs modified in positions 2 and 5.
    Yamashiro D; Li CH; Tseng LF; Loh HH
    Int J Pept Protein Res; 1978 Apr; 11(4):251-7. PubMed ID: 669882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response of plasma beta-endorphin immunoreactivity to d-amphetamine and placebo in schizophrenic patients.
    Schulz SC; van Kammen DP; Pickar D; Cohen MR; Naber D
    Psychiatry Res; 1982 Oct; 7(2):171-8. PubMed ID: 6292981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of beta-endorphin-like peptides from bovine brains.
    Swann RW; Li CH
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):230-3. PubMed ID: 6244546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some observations on the opiate peptides and schizophrenia.
    Watson SJ; Akil H; Berger PA; Barchas JD
    Arch Gen Psychiatry; 1979 Jan; 36(1):35-41. PubMed ID: 216330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis/hemofiltration in schizophrenia: a journey by night and cloud.
    Stephen RL; Velick SF; Kablitz C; Grosser BI
    Artif Organs; 1979 Feb; 3(1):31-7. PubMed ID: 435121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No correlation between neuroleptic-induced increase of beta-endorphin serum level and therapeutic efficacy in schizophrenia.
    Naber D; Nedopil N; Eben E
    Br J Psychiatry; 1984 Jun; 144():651-3. PubMed ID: 6146374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum concentration of beta-endorphin in schizophrenic and depressive diseases].
    Nagel S; Tegeler J; Goertz B
    Nervenarzt; 1982 Nov; 53(11):659-63. PubMed ID: 6294535
    [No Abstract]   [Full Text] [Related]  

  • 16. beta-Endorphin, cortisol, and prolactin in serum of schizophrenic patients during long-term neuroleptic treatment and after withdrawal: relationships to psychopathology.
    Naber D; Albus M; Muller F; Burke H; Welter D; Ackenheil M; Hippius H
    Psychopharmacol Bull; 1982 Oct; 18(4):224-6. PubMed ID: 6130563
    [No Abstract]   [Full Text] [Related]  

  • 17. beta-endorphin: synthesis of analogs with extension at the carboxyl terminus with high radioreceptor binding activity.
    Yamashiro D; Ferrara P; Li CH
    Int J Pept Protein Res; 1980 Jul; 16(1):70-4. PubMed ID: 6254896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Endorphin and schizophrenia.
    Berger PA; Watson SJ; Akil H; Elliott GR; Rubin RT; Pfefferbaum A; Davis KL; Barchas JD; Li CH
    Arch Gen Psychiatry; 1980 Jun; 37(6):635-40. PubMed ID: 7387335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that endogenous 6-(ARG or LYS)-opioid peptides can interact with kappa-receptors as agonists.
    Oka T; Negishi K
    Life Sci; 1982 Oct 18-25; 31(16-17):1707-10. PubMed ID: 6130430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous opioid activity and beta-endorphin immunoreactivity in CSF of psychiatric patients and normal volunteers.
    Naber D; Pickar D; Post RM; Van Kammen DP; Waters RN; Ballenger JC; Goodwin FK; Bunney WE
    Am J Psychiatry; 1981 Nov; 138(11):1457-62. PubMed ID: 6271019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.